BRAF and colorectal cancer: Mutated BRAF and KRAS oncogenes, both members of the Mitogen Activated Protein Kinase (MAPK) pathway, are respectively observed in approximately 10–20% and 35–42% of the sporadic colorectal cancers [11–13].